home / stock / evlo / evlo news

EVLO News and Press, Evelo Biosciences Inc. From 09/17/21

Stock Information
Company Name: Evelo Biosciences Inc.
Stock Symbol: EVLO
Market: OTC
Website: evelobio.com
Menu
EVLO EVLO Quote EVLO Short EVLO News EVLO Articles EVLO Message Board
Get EVLO Alerts

News, Short Squeeze, Breakout and More Instantly...
EVLO - SYRS, BGRY and OPAD among mid-day movers

Gainers: Helbiz HLBZ +135%. Corvus Pharmaceuticals CRVS +77%. Innate Pharma IPHA +37%. Worksport (OTCQB:WKSP) +20%. Priority Technology Holdings (NASDAQ:PRTH) +15%. Entasis Therapeutics (NASDAQ:ETTX) +15%. Capital Senior Living Corporation (NYSE:CSU) +13%. Evelo (NASDAQ:EVLO) +...
EVLO - Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines

CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new type of orally delivered medicines, today announced that the U.S. Patent and Trademark Office has issued a new composition of matter patent (No...

EVLO - Evelo Biosciences Appoints Iain McInnes, M.B.Ch.B, Ph.D, to Board of Directors

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Iain McInnes, M.B.Ch.B, Ph.D., to its Board of Directors. ...

EVLO - JOBY, FTFT and CLIR among mid-day movers

Gainers: Cellect Biotechnology (NASDAQ:APOP) +29%. Katapult (NASDAQ:KPLT) +27%. Innate Pharma (NASDAQ:IPHA) +25%. MongoDB  (NASDAQ:MDB) +24%. Draganfly (NASDAQ:DPRO) +22%. Future FinTech (NASDAQ:FTFT) +18%. Neonode (NASDAQ:NEON) +18%. Impel NeuroPharma (NASDAQ:IMPL) +15%. The L.S. Starre...
EVLO - Enveric Biosciences and Cellect Biotechnology among healthcare gainers; Forte Biosciences among losers

Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. Evelo Biosciences (NASDAQ:EV...

EVLO - Evelo Biosciences, Inc. (EVLO) CEO Simba Gill on Q2 2021 Results - Earnings Call Transcript

Evelo Biosciences, Inc. (EVLO) Q2 2021 Earnings Conference Call July 29, 2021 08:30 ET Company Participants Jessica Cotrone - Investor Relations Simba Gill - Chief Executive Officer Mark Plinio - Chief Commercial Officer Jonathan Zung - Chief Development Officer Mark Bodmer - President, R&...

EVLO - Evelo Biosciences, Inc. (EVLO) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Evelo Biosciences, Inc. (NASDAQ: EVLO) Q2 2021 Earnings Call Jul 29, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Evelo Biosciences, Inc. (EVLO) Q2 2021 Earnings Call Transcript

EVLO - Evelo Biosciences Reports Second Quarter 2021 Financial Results and Business Highlights

–EDP1815 Phase 2b data in psoriasis expected in 3Q 2021– –Finalized design of Phase 2 clinical trial of EDP1815 in atopic dermatitis; start of trial anticipated in 3Q 2021– –Strengthened leadership team with appointment of Mark Plinio as Chief Commerci...

EVLO - NRx Pharma, Cassava Sciences lead weekly healthcare gainers; Seres Therapeutics trail

Artystarty/iStock via Getty Images The healthcare stocks in the S&P 500 finished ~2.2% higher this week to outperform the ~2.0% gain recorded by the broader index over the past five-day period. While the stocks weighed down by their alleged involvement in the U.S. opioid crisis ...

EVLO - Seres Therapeutics extends losses as Goldman Sachs downgrades on trial setback

ChrisChrisW/iStock via Getty Images Goldman Sachs has lowered the rating on Seres Therapeutics (MCRB) to sell from neutral, citing the failure of the company to meet the primary endpoint for ulcerative colitis candidate SER-287 in a mid-stage trial. After losing more than half of market ...
Previous 10 Next 10